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Abstract: Evidence for the effectiveness of nicotine replacement therapy (NRT) for smoking-cessation
in pregnancy is weak. This has been attributed to insufficient dosing and low adherence. This study
investigated the acceptability of key messages and delivery modes for a behavioral intervention to
increase NRT adherence in pregnancy. Semi-structured telephone interviews were carried out with
pregnant or postpartum women aged ≥16 from across England, who had been offered NRT during
pregnancy as part of a quit attempt and who struggled to quit (n = 10), and a focus group with stop-
smoking specialists from across England (n = 6). The two data sources were coded separately using
a thematic approach and then integrated to compare perspectives. Women and specialists agreed
on message tone and delivery modes. However, views diverged on the most influential sources for
certain messages and whether some information should be given proactively or reactively. There
was also disagreement over which messages were novel and which were routinely delivered. This
study demonstrates the value of capturing and integrating different perspectives and informational
requirements when developing behavior-change interventions. The findings provide useful insights
for designing a pregnancy-specific NRT adherence intervention that is acceptable to both those who
will deliver and receive it.
Keywords: smoking cessation; pregnancy; nicotine replacement therapy (NRT); medication adherence
1. Introduction
Smoking during pregnancy is the leading avoidable cause of poor birth outcomes,
including risk of miscarriage, preterm birth, stillbirth, and low birthweight [1–5]. Smoking
rates among pregnant women have been slowly declining in high-income countries but
many women still find it difficult to stop; these women have an estimated prevalence of
8.1% in Europe and 5.9% in the Americas [6]. In England, the Department of Health and
Social Care introduced a national ambition to reduce the rate of smoking in pregnancy from
10.7% in 2017 to no more than 6% by 2022 [7], but there has been very little change since
then (9.9% in November 2020) [8]. The prevalence of smoking in pregnancy is significantly
higher among disadvantaged groups [9–11]. These women are often dealing with multiple
challenges and face barriers to accessing treatment services [12]. Reducing smoking in
pregnancy is therefore a continuing priority and action is urgently needed to ensure that
all pregnant women get the help they need to quit.
National guidelines in the UK, Canada, Australia, and New Zealand recommend
nicotine replacement therapy (NRT) for pregnant women who are unable to stop smoking
with behavioral support alone [13–16]. There is no evidence to date that NRT causes harm
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during pregnancy but its effectiveness for smoking cessation in this population remains
unclear: the 2020 Cochrane Review of nine placebo and non-placebo NRT trials found
low-certainty evidence of a clinically significant improvement in smoking cessation rates.
However, when only the six higher-quality placebo-controlled trials were included in
the analysis, NRT was found to work no better than the placebo for improving smoking
cessation in pregnancy [17]. There are two key factors that might explain this: (1) nicotine
clearance appears faster in pregnancy, so a higher NRT dose is likely needed to alleviate
withdrawal symptoms [18,19], (2) pregnant women can be reluctant to use NRT, and when
they do, adherence is generally poor [17].
There are many different reasons pregnant women fail to adhere to NRT, some of
which could be targeted by behavioral interventions. In line with the necessity–concerns
framework [20], research has shown that women are worried about the safety of NRT
in pregnancy. In particular, the concern is that it might increase their nicotine exposure
compared to smoking, potentially causing more harm to the fetus [21]. Experiencing
or anticipating negative side effects is also a major reason for NRT non-adherence and
discontinuation [21,22]. Our own qualitative work has reinforced these findings and also
revealed that some women believe NRT is unnecessary or ineffective, while others seek
to test whether they still need NRT by stopping prematurely, which can leave them more
vulnerable to relapse. Importantly, concerns about safety, nicotine intake, and nicotine
dependency are often heightened in the context of combination NRT (using a patch plus a
fast-acting NRT product) [23]. Healthcare professionals who deliver smoking-cessation
advice can also be cautious about NRT use in pregnancy, especially when it comes to
discussing topics such as safety [24,25] or use during a smoking lapse [26]. High-quality
evidence on NRT use in pregnancy, and what works to help women use it properly, is
therefore needed.
The N-READY (nicotine replacement effectiveness and delivery in pregnancy) pro-
gram aims to develop and test a behavioral intervention, called “Baby, Me & NRT”, to
improve adherence to NRT in pregnancy. This will enhance standard cessation advice
in a stop-smoking service setting, by providing additional practitioner training and new
information, educational materials, and tailored digital support for pregnant women. This
qualitative study aimed to elicit women’s and stop-smoking specialists’ views on key inter-
vention messages and how these might be delivered to assess and enhance acceptability.
The findings will be used to specify the prototype NRT-adherence intervention prior to
optimization and randomized controlled trial testing.
2. Materials and Methods
Semi-structured telephone interviews were conducted with women from across Eng-
land who had been offered or accepted NRT as part of a quit attempt during pregnancy. We
also ran a focus group with professionals who either directly supported pregnant women
to stop smoking or were involved in the organization of stop-smoking support (referred to
as ‘stop-smoking specialists’). Approval was granted by East Midlands—Nottingham 1
NHS Ethics Committee (reference: 12/EM/0388). We have adhered to the Consolidated
Criteria for Reporting Qualitative Research (COREQ) checklist [27].
2.1. Public Involvement
A public involvement advisory panel (PIAP) made up of four women who have expe-
rience of smoking in pregnancy (n = 2) or an interest in the topic (n = 2) was established to
offer insights into the N-READY program. Panel members were recruited through previous
research with pregnant women, personal contacts, and word of mouth. For this sub-study,
panel members were involved in the development of study and participant materials (e.g.,
topic guides for interviews/focus group, recruitment adverts, participant information
sheets), the development of intervention messages, and reviewing the qualitative findings.
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2.2. Participants and Recruitment
2.2.1. Interviews with Pregnant Women
We sought women who: were pregnant or had given birth in the last 6 months, were
at least 16 years old, had tried to quit smoking while pregnant, and had been offered
NRT to help them. Women were recruited via a paid Facebook advert campaign, which
was run from our N-READY Facebook page. This allowed us to target women based on
age and location. We set a maximum daily budget of £15 to manage the flow of women
registering an interest in taking part. Those clicking on the advert were directed to an online
registration form. To ensure that we captured the views of those who may find it hardest
to quit, the advert was worded to purposively target women who had declined NRT, who
had discontinued NRT prematurely or who had not cut out cigarettes completely whilst
using NRT. As we aimed to provide NRT-related intervention messages to this specific
population of women, which we have worked with before on NRT-related research [21,23],
we did not anticipate requiring a large sample before saturation occurred.
2.2.2. Focus Group with Stop-Smoking Specialists
Participants for the focus group were recruited via an email invitation sent to indi-
viduals involved in smoking cessation support for pregnant women in England, such as
stop-smoking practitioners or service leads. The contact list was compiled from health
professionals involved in a previous study who had agreed to take part in further research.
We aimed to recruit between 6–8 participants, which is considered the optimal size to allow
for rich discussion [28]. We anticipated fairly homogenous responses from our formative
research with this participant group [29].
2.3. Procedure
As part of the intervention development process and informed by the theoretical
domains framework (TDF) [30] and necessity–concerns framework [20], we developed
a draft intervention structure with a set of NRT-related key messages, which might be
used to address pregnant women’s behavior. These were either novel or already part of
the English National Centre for Smoking Cessation and Training’s (NCSCT’s) standard
treatment program for pregnant women [31] but considered essential for NRT adherence.
The messages were structured around seven themes: (1) NRT can help you quit, (2) NRT
is safe to use in pregnancy, (3) the importance of taking NRT as instructed, (4) tips for
taking NRT, (5) identifying and managing withdrawal symptoms and side effects, (6) NRT
use in a lapse, and (7) getting others on board with your quit attempt. The qualitative
data collection with women and specialists sought feedback on a selection of these key
intervention messages. The example messages presented to each participant group were
not identical, but there were eight similar issues associated with NRT use in pregnancy and
adherence to NRT discussed with both (see Table 1).
For the interviews with women, messages were emailed to participants beforehand.
A semi-structured topic guide was then used to identify what, if anything, would make
them more effective and improve acceptability. We also asked what participants considered
to be the best ways for these messages to be delivered. Verbal consent was obtained at
the beginning of the interview and a hard copy was sent to the women afterwards, along
with a £20 shopping voucher as a thank-you for taking part. The interviews took place
between January 2019 and March 2019, lasted an average of 67 min, and were conducted
by LM (PhD).
Focus group participants were shown PowerPoint slides that described the NRT
adherence-related issue to be addressed, example messages, and prompts to aid discussion.
The focus group took place at the University of Nottingham in February 2019, lasted three
hours, and was conducted by RT (PhD). Written consent was obtained on the day. Both
LM and RT are trained in and have considerable experience in conducting and analyzing
qualitative research.
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Table 1. Issues to address and associated intervention messages discussed in the interviews with women and the focus
group with stop-smoking specialists.
Issue to Address
Interviews with Pregnant and
Postpartum Women
Example Messages
Focus Group with Stop-Smoking
Specialists Example Messages
1 Concerns about NRT safety
NRT is much safer than smoking
because it doesn’t contain all the
harmful chemicals you get from smoke,
and these are the things that
cause the harm.
NRT has never been shown to
cause harm to babies.
2 Awareness nicotine is metabolizedfaster in pregnancy
Nicotine is processed more quickly by
the body during pregnancy and
therefore higher doses of NRT may be
needed to manage
withdrawal symptoms.
Nicotine is removed from your body a lot
more quickly when you are pregnant; this
means you need higher doses of nicotine to
prevent cravings.
3 Address concerns about nicotine 1(too much nicotine)
With combination NRT you are unlikely
to receive doses of nicotine that are
higher than you would receive from
tobacco use.
NRT gives you a lot less nicotine than you
would have received by smoking.
4 Addressing concerns about nicotine 2(NRT dependency)
Using NRT is not trading one nicotine
addiction for another. The way NRT is
delivered makes it much less addictive
than smoking and long-term
dependence on NRT is highly unlikely.
Using NRT is not trading one nicotine
addiction for another. The way NRT is
delivered makes it much less addictive than
smoking and long-term dependence on NRT,
even in high doses, is highly unlikely.
5 NRT can be usedthroughout pregnancy
It’s OK to use NRT throughout
pregnancy if instructed, as this will be
safer than going back to smoking.
It is OK to use NRT
throughout your pregnancy.
6 Continuing use of NRT during a lapse
If you were told to keep on using NRT
even if you were smoking a little (as a
means to helping you return to not
smoking at all), what would you think?
If you do start smoking for a short time do
not stop using the NRT (even if you
continue to smoke a little). Re-commit to
stopping and you can get back on track and
stop smoking.
Or:
Research shows that if you try stopping
smoking with NRT but lapse and smoke a
little, the baby will be exposed to less
tobacco smoke and no more nicotine than
just smoking.
7 Don’t stop NRT too early
Don’t decide to take NRT depending on
how you’re feeling—it is important to
take the whole course for as long and as
regularly as instructed, regardless of
withdrawal symptoms or how confident
about quitting you are feeling.
You can’t easily tell when NRT is working. If
NRT is doing its job then you probably
won’t notice it but don’t let this trick you
into thinking you’ve quit already and you
don’t need to keep taking it. It’s important
to take the NRT for as long as recommended
and don’t stop your NRT until you have
spoken to your stop-smoking practitioner.
8 Addressing concerns aboutside effects
Side effects are typically mild, don’t get
worse, and usually disappear—not a
sign of anything bad to come.
Or:
Side effects can usually be managed
using tips and tricks.
Like medicines, NRT products can have
side-effects but they are typically mild, don’t
get worse, and usually disappear. They are
not a sign of anything bad.
Or:
The side effects of NRT are dizziness,
headache, excessive sweating, nausea,
palpitations, skin reactions, vomiting. You
may experience these if you use too much
NRT but this is very unlikely.
2.4. Analysis
As the interviews and focus groups involved different topic guides, and the way the
intervention messages were presented to participants differed, these data were initially
coded separately. Feedback included whether message responses were positive or negative,
the perceived novelty of the messages, and thoughts on by whom, how, and when the
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messages might be delivered. We also sought to identify any new emergent themes from
the data that might help with refining the adherence intervention as a whole.
To begin, audio recordings were transcribed verbatim and a process of familiarization
was undertaken by reading each transcript and making notes. The intervention messages
in each topic guide informed the initial thematic frameworks. Nvivo 11 software was used
to facilitate data management, with coding undertaken independently by two researchers.
A summary of the key findings was then produced for both the interviews and the focus
group with suggestions for refinements to the protype intervention.
For a robust comparison of findings from the women’s interviews and the specialists’
focus group, we identified the issues and associated intervention messages that were
discussed across both. LM and RT then reviewed the summarized data relating to each of
these, along with views on delivery, to look for similarities and differences in perspectives
between the pregnant women and the specialists. Subsequent discussions identified three
themes that best explained the data (see Supplementary Figure S1). These were then used
as the framework for producing a comparison table. The findings from the comparison
exercise were discussed with the entire research team and our public involvement advisory
panel, to provide complementary perspectives.
3. Results
Thirty women registered an interest in the study, of which 10 were contactable and
consented to take part. Two women were using NRT and smoking, five had used NRT but
relapsed to smoking, one had used NRT but stopped and quit smoking unassisted, and
two had turned down the offer of NRT. Participants were aged between 16–39, the majority
were white British, and two thirds (n = 7) were living with a partner. Two were in the first
trimester (≤12 weeks gestation), four were in the second trimester (13–26 weeks), two were
in the third trimester (27–40 weeks), and two were in the postpartum period (0–6 months)
(see Table 2). The cost for recruitment was £11.96 per participant.
Table 2. Characteristics of pregnant and postpartum (PP) women.
ID Age Weeks Pregnant Ethnicity NRT-Related Experience
P1 Int 16 11 weeks White British Offered NRT but did not follow up. Having theoccasional puff on a cigarette.
P2 Int 29 9 weeks White British Using nicotine patch. Smoking up to5 cigarettes per day.
P3 Int 29 13 weeks White British Using nicotine gum intermittently/smoking4–5 cigarettes per day. Occasionally using a vape.
P4 Int 17 38 weeks White British Used nicotine patch and inhalator for a few weeks butnow relapsed. Smoking 15 cigarettes per day.
P5 Int 18 20 weeks White British Used nicotine patch <1 week (purchased herself).Smoking 2–3 cigarettes per day.
P6 Int 34 15 weeks White British
Used inhalator and nicotine gum for about 6 weeks but
stopped due to side effects. Continued quit attempt
alone and now nicotine free.
P7 Int 24 27 weeks White British Used nicotine patch and mints briefly but stopped.Smoking 10 cigarettes per day.
P8 Int 39 21 weeks Mixed White/Black Caribbean Used nicotine patch and mouth spray but stopped dueto side effects. Still smoking occasionally.
P9 Int 29 26 weeks PP White British
Used nicotine patch and mints, then tried the mouth
spray. Stopped NRT as did not feel it was working.
Now smoking 10 cigarettes per day but was 2 per day
at the end of pregnancy.
P10 Int 2 6 17 weeks PP White British
Offered NRT but did not accept. Concerns about using
in pregnancy. Has continued to smoke around
10 cigarettes per day.
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The focus group consisted of six participants who were either stop-smoking prac-
titioners (n = 3) or worked in the organization of stop-smoking-in-pregnancy services
(n = 3) (see Table 3). All came from different services from across England. Not all invited
specialists were able to participate due to their workload. The findings were organized
around three themes: (1) views on the novelty, value, and delivery timing of key interven-
tion messages, (2) message source and communication style, and (3) preferred modes of
delivery. Brief summaries and representative quotes for each theme are used for reporting
purposes. Quotes from participants are identified in the following manner: participant 1
from interviews (P1 Int), participant 1 from focus group (P1 FG).
Table 3. Characteristics of stop-smoking specialists.
ID Age Gender Job Title Experience
P1 FG 61 F Smoking cessation midwifery lead >10 years
P2 FG 45 F Stop-smoking-in-pregnancy specialist trainer >10 years
P3 FG 40 F Stop-smoking practitioner 2–5 years
P4 FG 48 F Stop-smoking practitioner 2–5 years
P5 FG 57 F Stop-smoking practitioner 2–5 years
P6 FG 56 F Stop-smoking-in-pregnancy specialist >10 years
3.1. Views on the Novelty, Value, and Delivery Timing of Key Intervention Messages
Within this theme, we look at each of the eight NRT adherence-related issues and
examine women’s and specialists’ views on the example messages designed to address
them in terms of novelty, informational preferences, and ideal message timing.
3.1.1. Addressing Concerns about NRT Safety (Issue 1)
Both women and specialists felt that emphasizing the safety of NRT was very impor-
tant. However, specialists were unsure about saying NRT was ‘safe’ in pregnancy because
in their view it was not completely risk-free. On the other hand, pregnant women thought
it was most important to focus on communicating the health benefits of using NRT rather
than talking about the risks, particularly for the baby, but they also wanted to know how
much safer NRT was when compared to smoking. It was suggested that this message
would be more persuasive and memorable if it stated an estimate of risk in terms of how
much safer NRT was: “More facts. State, like, how is it better? I mean, what percentage?”
(P9 Int).
3.1.2. Awareness That Nicotine Is Metabolized Faster in Pregnancy (Issue 2)
Interviewed women thought that the message they were presented with about in-
creased nicotine metabolism in pregnancy was very useful and should be given early on, as
it helped to explain why pregnant women might experience stronger nicotine cravings and
contextualized the need for higher NRT doses. However, very few women who received
NRT advice recalled being told this:
I didn’t know that. I’m a bit shocked by that, to be fair, because obviously I’ve been to see
somebody about stopping smoking and I didn’t get told that.
(P2 Int)
In contrast, specialists perceived that this type of message would already be rou-
tinely given during the first consultation but emphasized the need to deliver it in an
understandable way to have the intended impact: “If you explain it right, it lands quite well”
(P1 FG).
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3.1.3. Addressing Concerns about Nicotine Exposure and NRT Dependency
(Issues 3 and 4)
Women had concerns about nicotine and getting too much of it, even after receiving
the message that this was not the harmful substance in cigarettes. The message about
getting no more nicotine from combination NRT than from smoking tobacco was said to
be persuasive in terms of encouraging the use of two NRT products together and easing
concerns about nicotine exposure from NRT. However, it was not something any of the
women said they had heard before:
No, I just assume using two products would be double the amount of nicotine, so more
than what I’d be using in the first place. But to know that wouldn’t be the case [would be
good], I bet quite a few people think the same thing.
(P8 Int)
Specialists reported liking the message; however, they indicated that it was not information
women needed to be told at the outset but could be discussed if and when it came up in
follow-up consultations. The stop-smoking practitioners in the focus group said that they
would typically talk about getting clean nicotine from NRT rather than comparing different
levels of nicotine intake between NRT and smoking. If fact, they felt that women were
probably more worried about not getting enough nicotine:
I think again you’re down to having that conversation when that lady asks you, or if that
lady’s worried about having too much nicotine, then you can go into that conversation.
It’s not a sort of thing I’d be telling them right at the beginning.
(P4 FG)
If a woman had voiced a concern, then I would deliver this message but in my experience
the concern is more about it not being enough.
(P2 FG)
On the theme of nicotine, pregnant women also found the message that NRT is less
addictive than smoking reassuring, as for many, this thought had crossed their minds. It
was considered important to explain why this was the case. One woman suggested that
using NRT could be described as a nicotine “reduction program” (P6 Int). Again, specialists
only thought this message should be discussed if it was raised by a client:
I think that would come later on, you know, if they are becoming dependent on something.
I don’t think it’s something that I’d talk about straight away.
(P3 FG)
3.1.4. NRT Can Be Used throughout Pregnancy (Issue 5)
Most women thought that knowing NRT can be used throughout pregnancy and
beyond was useful, but this was not something they reported having heard before. Some
of those women who had received NRT advice described not being told how long they
should use NRT for at all: “Advisor did not indicate how long I would need to use NRT for.”
(P2 Int).
Specialists liked this message too, and some said that it was already being delivered.
However, the main concern with this message was whether commissioning would restrict
services from offering longer courses of NRT:
It depends on how you’re wording that message because it is OK for them to stay on
NRT throughout their pregnancy, but we don’t want to give them the assumption that
we’re going to give it to them, because we can’t. And different areas have different budget
constraints, so it might be worth having that caveat . . .
(P2 FG)
Specialists thought that explaining NRT can be used throughout pregnancy may not be
discussed until a follow-up appointment, and as part of this conversation, it would be
important to discuss how doses of NRT will be gradually reduced over time.
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3.1.5. Continuing to Use NRT in a Lapse (Issue 6)
The majority of pregnant women were very receptive to the message they received on
continuing NRT use during a lapse, as they would count a lapse (smoking one or more
cigarettes, but not totally relapsing to smoking) as failing and, so, some foresaw themselves
stopping NRT altogether in this situation. They believed that if women were given this
information from the outset, this would help them feel less like a failure and encourage
them to continue with their quit attempt:
Well, I think that would be good because without being told that, I’d think, “Oh well,
now I’ve had a cigarette I can’t have those patches and then I’ve failed so I need to stop
with the patches,” or something.
(P5 Int)
I would think that—I think that’s good and is encouraging in a way that it means “OK, I
mucked up, but don’t lose the hope.”
(P8 Int)
A few, however, were concerned about continuing to use NRT during a brief lapse; they
thought that they might take in too much nicotine, which could harm the baby and, so,
wanted more information about nicotine intake. Indeed, this concern had led some of the
women interviewed to alternate between NRT use and smoking:
P: I think more information on how much nicotine you’re taking [ . . . ] So, I had the
patches and then I’d take off the patch, have a fag, and then I tried to go back to it but
then that weren’t helpful either really, to be honest.
I: So, you’d take off the patch when you had the cigarette?
P: I think because I thought I’d be taking in too much nicotine.
(P7 Int)
However, interestingly, when specialists were shown a message which might address these
concerns, which explained that if pregnant women use NRT and smoke they will probably
be exposed to no more nicotine than smoking alone, most felt “uncomfortable” or “didn’t
agree” with the message:
I feel quite uncomfortable with it. I’d probably need to see more in the way of evidence
because it seems to go against everything that we’ve done previously.
(P2 FG)
I think this research is good for us to know but we really don’t need to be telling anybody
else about it.
(P4 FG)
Some of the women interviewed thought that being told to continue NRT in a short
smoking-lapse period might encourage pregnant women to think it is acceptable to smoke
and use NRT generally. Likewise, most specialists thought that this message might give
women permission to fail, so did not think women should be given this information upfront:
I think this would be quite a difficult message to give. It’s one of those where you don’t
kind of want to give it because it’s almost like saying “Oh, you might smoke a bit”. It’s
almost pre-empting that they are going to slip up.
(P5 FG)
. . . [it might give them] that confidence to think “Well, I can just have a cigarette
whenever I want one” and that’s when you start sliding down the slippery slope again.
(P3 FG)
Although they did appreciate that there may be instances where this information could
be useful:
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I think it’s a message for us to know and for us to use if needs be.
(P4 FG)
. . . It’s more reactive as opposed to proactive.
(P1 FG)
3.1.6. Don’t Stop NRT Too Early (Issue 7)
Both women and specialists thought the messages relating to prematurely stopping
NRT were positive and agreed that women should be given this information in the first
consultation. A number of the women drew parallels with antibiotics, where the advice
is to take the full prescribed course of treatment. Similarly, one specialist likened NRT to
using painkillers: “You don’t know that that pain’s there until you stop taking them, so you’re
sort of fooled into thinking that you’re OK” (P2 FG). While another said that this message tied
in well with explaining the duration of treatment.
3.1.7. Addressing Concerns about Side Effects (Issue 8)
Both women and specialists thought that it was a good idea to refer to NRT as a
“medicine”. Some specialists were concerned about suggesting side effects were likely to
be temporary and “usually disappear” as the term “usually” could be off-putting: “ . . .
they usually disappear? I suppose if I read that I’d be picking up on “usually”.” (P2 FG). However,
women found this information reassuring.
Specialists were also uncertain about discussing side effects at the first consultation
because this may give women an excuse as to why they do not want to continue with NRT:
Sometimes these are reasons why women then decide not to carry on. I really think it’s
about boosting their ability to quit and if you tell them that they might get all these things,
“I’m not going to bother, then”.
(P3 FG)
However, side effects might be discussed upfront if it came up during a conversation about
previous NRT use: “Then quite often it’s, “Oh, I couldn’t use them because my arm comes up”,
or, “I’ve tried this”.” (P1 FG). On the other hand, women felt it was important to establish
expectations at the outset of treatment and to know that there are ways to minimize side
effects. For some, this might have made them persevere with taking NRT for longer:
I think so, because, obviously, where I was feeling sick, I think if I’d have heard that or
been told that then I may have stuck it out a bit longer.
(P4 Int)
3.2. Message Source and Communication Style
When asked about the most influential sources for different messages, women indi-
cated that they would like real-life stories when receiving information about the harms of
smoking in pregnancy or insights about using NRT. For example, one participant said “
. . . I mean, they’ve gone through the same thing—the irritation [with a patch]—so if there’s a way
they can help someone else stop that, it would encourage them to carry on” (P9 Int). Women also
wanted to hear “realistic” accounts from former pregnant smokers who had quit with NRT:
Because you find that a lot with the professionals and things—yes, obviously, they know
more about it but they read from a textbook, you know, and to have somebody that’s in
your situation or been in your situation and knows what you’re going through and seeing
they’ve come out the other side would be very helpful.
(P2 Int)
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You want to hear of people who have started and probably struggled. It would probably
help more if they’ve struggled, gone on their own and then gone back to it and actually
finished the course [of NRT], proved themselves wrong, but proved that they’ve got to
finish the course for it to work properly.
(P9 Int)
Specialists recognized that the experiences of others, such as friends and family, could be
influential, but also cautioned that this was often a source of misinformation.
A lot of the mums we see, you know, whatever their friends say or their mum’s said, you
know, if they’ve heard that first then, like, it is hard to overcome that, isn’t it? It’s doable
but you do need to get that rapport with somebody.
(P5 FG)
Women expressed an interest in hearing “facts” and “research” for more medical-related
issues, such as NRT safety in pregnancy, the likelihood of long-term addiction to NRT or
continuing to use NRT in a brief lapse. This information was considered best delivered by
health professionals or other leading health experts:
Dealing with these concerns that people might have, to have some sort of expert, like
authority on nicotine replacement therapy in pregnancy to, sort of, be saying, ‘This is,
sort of, the most up to date, what we know’.
(P4 Int)
Cite research—that’s what you need, straight to the point, you know, that’s what you
need to be able to just know that and then that can put people’s minds at ease.
(P2 Int)
However, specialists were of the opinion that pregnant women would not be particularly
interested in listening to academics or talk about “scientific” information:
I think it should be a mix of midwives and Stop-Smoking Advisors rather than Professor
X [ . . . ] and speaking about scientific findings, I’m not sure that the women I work with
would be particularly [persuaded].
(P2 FG)
Both specialists and women agreed on the importance of consistency and keeping messages
simple: “ . . . you just want a load of clear, key points and you know what you’re doing” (P9 Int).
In terms of message tone, pregnant women indicated that messages should be supportive
and encouraging:
I just think support and encouragement when you’re trying to do something like that is
what you need.
(P2 Int)
Which was echoed by specialists:
And you want to give them as much positivity and encouragement and confidence that
they’re going to be fine, you know.
(P6 FG)
3.3. Preferred Message Delivery Modes
Interviewed women and stop-smoking specialists both said that it might be advanta-
geous to use different delivery modes to ensure that pregnant women receive messages in
an appropriate manner. This could include a combination of practitioner support, along
with digital solutions such as a website, text messages, videos, and/or an app. There was
recognition that people have different learning styles and that repetition across different
media might be advantageous:
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It wouldn’t hurt for it to be heard more than once, definitely, like anything. And also, you
know, to hear it perhaps in a different form rather than just verbal because some people
don’t hear you talking, they might need to see it written down or something.
(P4 FG)
. . . some videos and stuff like that. Because videos always make—well, I prefer to watch
videos than actually read. And it would just be good to get some of the information across.
Especially people’s personal views.
(P4 Int)
Specialists thought that a website would be a good place to emphasize key content and
include information that they might omit from the first consultation:
I think where it would have a place is if you had something like a website with myths and
things like that. Myth—you will become addicted to NRT—false, blah, blah, blah. So
that’s where it would have a place so it can be addressed as a sort of myth-buster.
(P1 FG)
If they were experiencing something [side effect] that they could then look up because
that’s what they do, they phone instead of looking it up first.
(P3)
Specialists reported a lack of trusted resources that were relevant to using NRT in pregnancy
but, although a dedicated website seemed like a good idea, they cautioned that an app
might be more suited to the target population:
I think an app would also be more accessible to more women than a website specifically
because you’ve got to think about the age group of people getting pregnant and partic-
ularly the younger generation . . . I know you can get websites on your phone but it’s
more user-friendly in an app form.
(P1 FG)
A number of pregnant women also suggested that “online forum where people can all talk
together” (P9 Int) might be useful, but this was not raised in the specialist focus group.
4. Discussion
This qualitative study identified similarities and differences in the views of women
and specialists on key messages for an intervention to improve adherence to NRT in
pregnancy. There was general agreement in terms of message tone and the best methods for
delivery. However, women and specialists had differing views on whether or not messages
were novel, the most influential sources for certain messages, how best to communicate
research evidence, and the timing of message delivery. These findings demonstrate the
value of capturing and integrating different perspectives and informational requirements
when developing behavior-change interventions.
In this study, specialists were sometimes resistant to proactively discussing women’s
concerns about NRT or to provide them with information to cope with an issue before it
happened. This particularly related to potential side effects, nicotine intake, and continuing
NRT use in a smoking lapse. Evidence has shown that health professionals might contribute
to poor adherence by withholding information because they think it will deter patients from
taking medication [32], and that positively framed risk information might help improve
use [33,34]. Meanwhile, on the other hand, patients often voice frustration about not
receiving as much information about medication side-effects or risks as they would have
liked, believing that full disclosure would help them make more informed treatment
decisions [35]. A recent qualitative study that focused on how women make decisions
about medication in pregnancy found that many of the women wanted to move beyond
the basics and know about the risks and benefits of medication use upfront. Not only
can this support informed choice, but having realistic perceptions might help to reduce
anxieties [36]. The women in our study seemed particularly interested in knowing what to
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do in a smoking lapse, but specialists had strong concerns about recommending continued
NRT use in this situation. Identifying what constitutes a lapse, as opposed to a full relapse,
and the appropriate management with NRT in this population, are matters that warrant
further research [26].
We also identified specialist uncertainty about what could be said in relation to NRT
in pregnancy. Yet most women felt they needed clear and unequivocal information to
help them make decisions about NRT use. For example, to offer an estimate of how much
safer NRT is than smoking might be particularly memorable and persuasive. Practitioner
uncertainty can often arise from a lack of knowledge or lack of evidence [37] and can
result in inconsistent information provision. Specialist training for practitioners could give
them the knowledge and confidence to deliver enhanced NRT support in pregnancy and a
stronger evidence base regarding exposure to nicotine from smoking and NRT could help
inform such training.
In terms of information sources, women thought that messages on the consequences
of smoking in pregnancy and using NRT were considered more persuasive if they came
from another’s personal experience. Hearing stories from women who have successfully
quit smoking, and the opportunity to communicate with those also trying to quit, has
previously been identified by pregnant women as a useful feature in smoking cessation
interventions [38,39]. Indeed, Coley et al. [40] argued that smoker-informed content is more
realistic to experience and therefore it may help to maintain engagement with interventions.
However, the effect of peer interventions on smoking cessation outcomes in pregnancy
is unclear [41,42] and they can be difficult to implement. This may be an opportunity for
practitioner storytelling, using anonymous anecdotes or sharing videos or case studies
of other pregnant women’s quit attempts with NRT; however, there is limited literature
looking at the effects of this on smoking cessation. Online social networks have grown
in popularity, and there is some emerging evidence that these have a positive effect on
health-behavior change in the general population [43,44] with studies focusing on smoking
cessation showing a moderately beneficial effect [45,46]. Further research is needed that
specifically focuses on pregnant women, and to establish what role this type of support
might play as part of a broader behavioral intervention. As noted by specialists in this
study, the potential risks that arise from peer-to-peer communication also need to be
carefully considered, as careful training and/or moderation is required, where appropriate,
to minimize the spread of misinformation or judgement [47].
Using ‘credible experts’ to deliver support for smoking cessation in pregnancy has
been identified as a common behavior-change technique in effective interventions [48]. Our
findings also emphasized the need for evidence-based information from experts, which for
women included health professionals or individuals with authoritative knowledge. Indeed,
the feedback from women suggested that talk about ‘evidence’ and ‘research findings’ was
more familiar and compelling than the specialists thought it would be. While some argue
that there is not a one-size-fits-all approach to effectively discussing relevant information
about the risks and benefits of a medical treatment [49], creating simple standardized text in
collaboration with pregnant women might be a helpful way for stop-smoking practitioners
to improve communication of the latest evidence-based information. Using the ‘teach-back’
method, whereby health professionals check they have explained information in a way
that has been understood, might also be a helpful approach [50].
Some messages came as a surprise to pregnant women, such as increased nicotine
metabolism during pregnancy, even though specialists perceived that these were routinely
delivered. This could highlight women’s poor recall of particular information, with the
effects of stress and anxiety thought to have a detrimental effect on memory performance
in the clinical setting [51]. However, another important possibility regarding the perceived
novelty of certain intervention messages might be differences in provider time and com-
petence. Studies exploring the fidelity of NHS behavioral support for smoking cessation
have shown inconsistency between services, with some studies showing that around one
third of recommended content is typically not delivered [52,53]. This essential content
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may therefore need reinforcing via further in-services training or continuing professional
education with practitioners to help maintain essential competencies and improve NRT
adherence. A consultation checklist might also ensure that key messages to promote NRT
adherence are not forgotten.
When designing and developing behavior-change interventions, it is not only impor-
tant to understand the techniques and mechanisms that lead to change but also the factors
which might influence implementation in real-world settings [54]. The involvement of
health professionals and service users in that process is both important and challenging
when developing complex interventions [55], and taking into account the views of both
of these stakeholders identified areas of consideration that may not have been discovered
by consulting with either group exclusively. Consensus between the groups allowed us to
identify areas of content tone and delivery that could be strengthened in any new interven-
tion. However, divergent views between the groups were arguably more informative as
they identified areas where there may be a need for increased focus (e.g., around periph-
eral treatment advice) or the open discussion around potentially sensitive subjects (e.g.,
treatment side effects).
5. Strengths and Limitations
Strengths of the work include the integration of women’s and specialists’ perspectives
and the use of intervention messages informed by existing evidence and theory to stimulate
feedback and discussion. However, this study has a number of limitations. The pregnant
women interviewed did not attend the same services that the specialists represented. Given
the variety of stop-smoking service models and contexts of delivery, this may explain why
there were differences between the information women said they wanted and was new to
them, versus what specialists believed was already delivered. Nevertheless, by recruiting
a diverse sample we were able to highlight potential delivery gaps. While the focus
group had sufficient participants to facilitate a blend of perspectives and encourage candid
responses, specialists were only able to talk about their own practice and service. Caution,
therefore, must be taken when interpreting the findings as they only represent the views of
a specific group. Moreover, we recognize that due to changes in commissioning [56] and
budgetary constraints, there are different models for delivering stop-smoking support in
pregnancy. Therefore, the findings may not be representative of England as a whole. This
also applies to the interviews with women, as the sample was predominantly composed of
white British women. However, the online recruitment method facilitated engagement with
women from disadvantaged backgrounds, who often disengage with stop-smoking services
and may be missed using service-based recruitment. A drawback to using telephone
interviews is that visual aids cannot be used to prompt discussion. Even though women
were sent example messages in advance, we cannot be certain that they had read them.
When considering different intervention messages and delivery modes it may be useful
to show examples during the interview and use a ‘think aloud’ approach [57]. There
was insufficient time to undertake any repeat interviews or participant checking, due to
constraints in the timetable of the overall study. However, findings from the comparison
exercise were discussed with our PIAP, which helped to provide another perspective on
the analysis and shape the conclusions.
6. Conclusions
The findings highlight how women and stop-smoking specialists can have differing
views on the acceptability, delivery, and content of key intervention messages to promote
adherence to NRT in pregnancy. Views differed on how best to communicate key messages,
with specialists particularly cautious about imparting some information upfront, such as
about side effects or handling a lapse contrary to the women’s views. However, a number
of novel or not yet routinely delivered messages about NRT use in pregnancy were liked by
both groups of participants. The present findings highlight the importance of taking into
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account the perspectives of both those delivering and receiving a behavioral intervention
at the development stage, in order to improve acceptability and feasibility.
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